- Advertisement -

Global White Biotechnology Market to Reach $581 Billion by 2027 – GlobeNewswire

New York, March 05, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global White Biotechnology Industry" - https://www.reportlinker.com/p06033301/?utm_source=GNW In addition to...

Centre for industrial biotechnology opened – The News International

Islamabad : COMSATS Joint Centre for Industrial Biotechnology (CCIB) was inaugurated today in Tianjin, China. The Centre is to become the regional hub for...

StockWatch: Parabilis Medicines Makes Wall Street History with $770.5M IPO

In what’s shaping up to be a historic year for biotech initial public offerings, Parabilis Medicines (Nasdaq: PBLS) made its mark on Wall Street this past week...

UAB researchers reverse liver disease in mice with gene therapy

UAB researchers have reversed metabolic dysfunction-associated steatohepatitis (MASH) in mouse models. MASH is a severe liver disease associated with obesity and type 2 diabetes...

AI-designed T-cell vaccine extremely effective at preventing severe COVID-19 in mice

The current COVID-19 vaccines are designed to trigger an antibody response to the SARS-CoV-2 spike protein, which is vulnerable to mutations that could make...

Mobile telehealth system used in China to enable clinical communication during...

A mobile telehealth system (MTS) has been used in a hospital in China where COVID-19 patients were treated in isolation wards set off from...

New Catalytic Reactive-Hydrogen Membranes Capture and Break Down PFAS

Researchers at Arizona State University (ASU) and collaborating institutions have developed catalytic reactive-hydrogen membranes that capture and chemically break down six per- and polyfluoroalkyl...

Diasome’s HDV-Insulin for T1D Finalizing Phase III Plans After Promising Data

Glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists have revolutionized the treatment of type 2 diabetes (T2D). None of these blockbuster...

New Catalytic Reactive-Hydrogen Membranes Capture and Break Down PFAS

Researchers at Arizona State University (ASU) and collaborating institutions have developed catalytic reactive-hydrogen membranes that capture and chemically break down six per- and polyfluoroalkyl...

Diasome’s HDV-Insulin for T1D Finalizing Phase III Plans After Promising Data

Glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists have revolutionized the treatment of type 2 diabetes (T2D). None of these blockbuster...

ADC Developmentfrom Concept to Clinic

Read Now Antibody-drug conjugates (ADCs) combine the specificity of monoclonal antibodies with the therapeutic activity of small molecule payloads, enabling targeted delivery...

more new items

New Catalytic Reactive-Hydrogen Membranes Capture and Break Down PFAS

Researchers at Arizona State University (ASU) and collaborating institutions have developed catalytic reactive-hydrogen membranes that capture and chemically break down six per- and polyfluoroalkyl...

Diasome’s HDV-Insulin for T1D Finalizing Phase III Plans After Promising Data

Glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists have revolutionized the treatment of type 2 diabetes (T2D). None of these blockbuster...

ADC Developmentfrom Concept to Clinic

Read Now Antibody-drug conjugates (ADCs) combine the specificity of monoclonal antibodies with the therapeutic activity of small molecule payloads, enabling targeted delivery...